{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:49Z","timestamp":1791041929702,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejmg.2022.104630","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:46:21Z","timestamp":1664498781000},"page":"104630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Succesful MEK-inhibition of severe hypertrophic cardiomyopathy in RIT1-related Noonan Syndrome"],"prefix":"10.1016","volume":"65","author":[{"given":"Anne","family":"Leegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille A.","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine \u00d8.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper V.","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Handrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejmg.2022.104630_bib1","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104630_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","article-title":"Gain-of-function mutations in RIT1 cause noonan syndrome, a RAS\/MAPK pathway syndrome","volume":"93","author":"Aoki","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"30","key":"10.1016\/j.ejmg.2022.104630_bib3","doi-asserted-by":"crossref","first-page":"15641","DOI":"10.1074\/jbc.M116.714196","article-title":"Biochemical classification of disease-associated mutants of RAS-like protein expressed in many tissues (RIT1)","volume":"291","author":"Fang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2022.104630_bib4","series-title":"Phase 1 Trial of Trametinib Alone and in Combination with Dabrafenib in Children and Adolescents with Relapsed Solid Tumors or Neurofibromatosis Type 1 (NF1) Progressive Plexiform Neurofibromas (PN)","first-page":"10537","volume":"vol. 36","author":"Geoerger","year":"2018"},{"issue":"46","key":"10.1016\/j.ejmg.2022.104630_bib5","doi-asserted-by":"crossref","first-page":"16395","DOI":"10.1073\/pnas.1418126111","article-title":"K-RasV14I recapitulates noonan syndrome in mice","volume":"111","author":"Hern\u00e1ndez-Porras","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ejmg.2022.104630_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/pbc.25546","article-title":"Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1","volume":"62","author":"Jousma","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104630_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cge.12608","article-title":"Mutations in RIT1 cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype","volume":"89","author":"Koenighofer","year":"2016","journal-title":"Clin. Genet."},{"issue":"12","key":"10.1016\/j.ejmg.2022.104630_bib8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2016.32","article-title":"Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation","volume":"18","author":"Kouz","year":"2016","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2022.104630_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.c.31765","article-title":"Congenital heart defects in Noonan syndrome: diagnosis, management, and treatment","volume":"184","author":"Linglart","year":"2020","journal-title":"Am. J. Med. Genet., Part C: Seminars in Medical Genetics"},{"issue":"1","key":"10.1016\/j.ejmg.2022.104630_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6442-2","article-title":"A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK\/ERK pathway: TRAM-01","volume":"19","author":"Perreault","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ejmg.2022.104630_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejmg.2022.104630_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104630_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104630_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J. Clin. Invest."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222002117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222002117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:29Z","timestamp":1761710009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721222002117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1769721222002117"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104630","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Succesful MEK-inhibition of severe hypertrophic cardiomyopathy in RIT1-related Noonan Syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104630"}}